Quantification of the PGD2 urinary metabolite 9 alpha-hydroxy-11, 15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid by stable isotope dilution mass spectrometric assay.
D002851:Chromatography, High Pressure Liquid / Q000379:methods; D006801:Humans; D007201:Indicator Dilution Techniques; D013058:Mass Spectrometry / Q000379:methods; D011453:Prostaglandins / Q000652:urine*; D011457:Prostaglandins D / Q000652:urine*; D014582:Urticaria Pigmentosa / Q000652:urine
D011453:Prostaglandins; D011457:Prostaglandins D; C035860:9-hydroxy-11,15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid